| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 06/26/2012 | US8207152 Methods for treating or preventing cancer by preventing, inhibiting, or arresting cell cycling |
| 06/26/2012 | CA2669753C Therapeutic treatment of androgen receptor driven conditions |
| 06/26/2012 | CA2545704C Novel 17.beta.-hydroxysteroid dehydrogenase type i inhibitors |
| 06/21/2012 | WO2012083201A1 Steroid tetrol solid state forms-2 |
| 06/21/2012 | CA2821967A1 Steroid tetrol solid state forms-2 |
| 06/20/2012 | EP2012773B1 Drugs and uses |
| 06/19/2012 | CA2522784C Antiandrogens with marginal agonist activity and methods of use |
| 06/14/2012 | WO2010076811A3 Process for the preparation of exemestane |
| 06/12/2012 | US8198041 Method of producing tibolone metabolites by fermentation with Cunninghamella elegans |
| 06/07/2012 | WO2012037261A3 6-substituted demethyl-estradiol derivatives as er-beta agonists |
| 06/07/2012 | US20120142656 Buccal application system comprising 17a-estradiol |
| 06/07/2012 | US20120142644 Method for producing phytosterol/phytostanol phospholipid esters |
| 06/06/2012 | CN101830937B Visualized double-reaction tube fluorine-18 multifunctional automated synthesis module |
| 06/05/2012 | CA2670236C Therapeutic treatment of androgen receptor driven conditions |
| 05/30/2012 | EP2456779A2 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases |
| 05/30/2012 | CN1700920B Phophylactic and therapeutic use of hydroxysteroids |
| 05/22/2012 | US8183401 Aromatase inhibitor; deprotonation |
| 05/16/2012 | CN102453068A Improvement preparation method for oxabolone cipionate |
| 05/10/2012 | WO2012059803A1 Improved process for preparation of estradiol valerate and a novel crystalline form a of estradiol divalerate |
| 05/09/2012 | CN101693734B Method for synthesizing 4-oxhydryl-4-olefin-3-ketone steroid |
| 05/08/2012 | CA2531905C Specific glucocorticosteroid compound having anti-inflammatory activity |
| 05/02/2012 | CN102432657A Method for extracting and purifying 4-androstenedione |
| 05/02/2012 | CN101429224B Synthesis of 1,4-diene-6-methylene steroids and intermediate thereof |
| 05/01/2012 | US8168621 6-substituted estradiol derivatives and methods of use |
| 04/26/2012 | US20120101052 15-thia steroid compounds and compositions |
| 04/17/2012 | US8158612 Methods of treating disease states using antiangiogenic agents |
| 04/10/2012 | CA2528483C Compositions and methods for increasing telomerase activity |
| 04/05/2012 | US20120082715 Stabilized products, processes and devices for preparing the same |
| 04/04/2012 | CN102399253A 一种坦勃龙醋酸酯的制备方法 A method of preparing the dragon acetate 坦勃 |
| 04/03/2012 | US8148558 Method of producing tibolone metabolites by fermentation with Fusarium lini |
| 04/03/2012 | US8148557 Method of producing tibolone metabolites by fermentation with Gibberella fujikuroi |
| 04/03/2012 | US8148556 Method of producing tibolone metabolites by fermentation with Rhizopus stolonifer |
| 04/03/2012 | US8148355 Phophylactic and therapeutic use of hydroxysteroids |
| 04/03/2012 | CA2472650C Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex |
| 03/28/2012 | CN102391341A Method for preparing 6,7-dehydro-17beta-hydrocarbon acyloxy nandrolone |
| 03/27/2012 | CA2389570C Methods for treating mild cognitive impairment |
| 03/22/2012 | WO2012037261A2 6-substituted demethyl-estradiol derivatives as er-beta agonists |
| 03/22/2012 | US20120071455 6-substituted demethyl-estradiol derivatives as selective er-beta agonists |
| 03/22/2012 | US20120071454 Steroid Compounds and Treatment Methods |
| 03/22/2012 | CA2809639A1 6-substituted demethyl-estradiol derivatives as selective er-beta agonists |
| 03/20/2012 | CA2577497C 15.beta.-substituted steroids having selective estrogenic activity |
| 03/15/2012 | WO2012032529A1 Stereoselective reduction of alpha-hydroxyketone |
| 03/15/2012 | US20120065180 Androgen pharmaceutical composition and method for treating depression |
| 03/15/2012 | US20120065179 Prodrug comprising beta-keto carboxylic acid, beta-keto carboxylic acid salt or beta-keto carboxylic acid ester for drug delivery |
| 03/14/2012 | CN102372756A Specific glucocorticosteroid compound having anti-inflammatory activity |
| 03/08/2012 | US20120058981 Androgen pharmaceutical composition and method for treating depression |
| 03/08/2012 | US20120055079 Products from step-wise extraction of algal biomasses |
| 03/07/2012 | EP1709062B1 Exemestane and its intermediates and methods of making the same |
| 03/01/2012 | WO2011156631A3 Methods and compositions to extract carbon-based products from host cells |
| 03/01/2012 | US20120052757 Molecularly imprinted polymers |
| 02/28/2012 | US8124614 Steroidal compounds for inhibiting steroid sulphatase |
| 02/28/2012 | US8124598 Administering 3-acetyl-7-oxo-dehydroepiandrosterone (7-keto DHEA) together with a carrier to treat to improve symptoms of depression, anxiety, bipolar, trauma; antiglucocorticoid; neuroprotective |
| 02/23/2012 | US20120045429 Methods and Agent for Modulating the RNA Polymerase II-Histone Surface |
| 02/22/2012 | CN102358750A Helix 12 directed pharmaceutical products |
| 02/22/2012 | CN102357247A Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 02/09/2012 | WO2011127232A3 Substituted androst-4-ene diones |
| 02/02/2012 | WO2012013816A1 Compounds and methods for treating neoplasia |
| 02/01/2012 | CN102336830A Anti-nandrolone specific antibody |
| 01/31/2012 | US8106036 Pharmaceutical compositions-4 |
| 01/26/2012 | WO2012011106A1 Process for the preparation of 17-desoxy-corticosteroids |
| 01/18/2012 | EP2407475A2 Synthetic Bile Acid Composition, Method, and Preparation |
| 01/18/2012 | CN101010332B Process for the preparation of estrone and/or estradiol-derivates |
| 01/11/2012 | CN102311473A Toonapubesic aldehyde and preparation method as well as application thereof |
| 01/10/2012 | CA2492079C Microbiological processes for the production of 7 alpha-substituted 11 alpha-hydroxy steroids |
| 01/10/2012 | CA2440605C Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 01/04/2012 | EP2401288A1 Digital microfluidic liquid-liquid extraction device and method of use thereof |
| 01/03/2012 | US8088758 17β-hydroxysteroid dehydrogenase type I inhibitors |
| 12/22/2011 | US20110312929 Treatment of vaginal atrophy in women with cardiovascular pathology risk |
| 12/13/2011 | US8076316 Steroid compounds and formulations |
| 12/08/2011 | US20110301363 Method for carrying out oxidation reactions using inductively heated heating medium |
| 12/08/2011 | CA2801426A1 Combination cancer therapies with wortmannin analogs |
| 12/07/2011 | EP2283025B1 5-fluoro-3alpha ,17beta-dihydroxy-5alpha-androstan-6-one, the method for its production and its use for influencing plant growth |
| 11/30/2011 | EP2390260A2 Ester derivative of ethinyl estradiol |
| 11/30/2011 | CN102260312A 雌二醇及雌二醇苯甲酸酯的绿色还原制备方法 Green reduction Preparation of estradiol and estradiol benzoate |
| 11/24/2011 | US20110288288 Process for the preparation of 17-0-vinyl- triflates as intermediates |
| 11/24/2011 | US20110286958 Hpma polymer platinum chelates |
| 11/23/2011 | CN101289487B 17 beta-amino steroidal estrogen and androst without blood coagulation activity and method for preparing same |
| 11/22/2011 | CA2664720C Vitamin d derivatives |
| 11/10/2011 | WO2011138460A1 Progesterone receptor antagonists and uses thereof |
| 11/09/2011 | EP1343508B1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis |
| 11/08/2011 | US8053426 Progesterone receptor antagonists |
| 11/03/2011 | US20110269725 Novel estrogenic compounds |
| 11/03/2011 | US20110269689 High penetration compositions and their applications |
| 11/02/2011 | CN102229635A Process for the preparation of estrone and/or estradiol-derivates |
| 11/01/2011 | CA2531911C Specific glucocorticosteroid having an anti-inflammatory activity |
| 11/01/2011 | CA2450231C System and method for the large scale labeling of compounds with radiohalogens |
| 10/27/2011 | WO2011098439A3 A process for introducing a double bond into position 15,16 of a steroid |
| 10/27/2011 | US20110262540 Solid Pharmaceutical Composition Comprising Exemestane |
| 10/26/2011 | EP2380898A1 Process to make glucocortisoid compounds |
| 10/26/2011 | CN102227441A Processes and intermediates for production of fulvestrant |
| 10/20/2011 | WO2011066542A3 6-substituted estradiol derivatives and methods of use |
| 10/13/2011 | WO2011127232A2 Substituted androst-4-ene diones |
| 10/13/2011 | CA2794565A1 Substituted androst-4-ene diones |
| 10/12/2011 | CN102212099A Synthesis method for dehydroepiandrosterone |
| 10/05/2011 | CN1845933B Specific glucocorticosteriod compound having anti-inflamatory activity |
| 10/05/2011 | CN101456888B Method for preparing methenolone |
| 10/04/2011 | US8030298 17β-HSD1 and STS inhibitors |
| 10/04/2011 | US8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 09/27/2011 | US8026229 Inhibiting tubulin polymerization; treating prostate and breast cancer |
| 09/22/2011 | WO2011114220A1 Neuro-protective effects of adelostemma gracillimum and its isolated compounds |